AzTrials
AzTrials

Arthritis, DegenerativeNavioRCTNCT04525950

Robotized Navigation Compared to Conventional Technique in Total Knee Replacement

A study testing Navio and Conventional in people with Arthritis, Degenerative and Osteo Arthritis Knee, run by Haukeland University Hospital at 2 sites in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Navio is a new generation of computer navigation systems allowing intraoperative navigation of the bone cuts relative to both ligaments and skeletal axes, prior to bone removal. An improved accuracy is incorporated by the use of robotics in a burr for bone removal. Read more about this study

Who is it for?
Ages 45 to 85 years
Conditions the study is for
Arthritis, Degenerative, Osteo Arthritis Knee
What is being tested?
Navio and Conventional
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
214 participants
Where
2 sitesNorway
Study dates
7 Sep 2020to 31 Dec 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Degenerative knee in need of a total knee arthroplasty
  • Recruited from the hospital's waiting list
  • Informed consent

Who cannot join

  • Severe systemic illness
  • Infections
  • Severe neurological dysfunction
  • Severe cancer disease
  • Severe incompensated heart failure
  • Severe incompensated lung disease
  • Dementia
  • Previous fracture or deformity of the limb, making the use of an intramedullary rod impossible (same side hip or ankle implant is not to be excluded if the rod unaffectedly reaches more than the first half of the femoral canal)

Trial locations and contacts

2 sites in 1 country.

Norway2 sites
  • Haukeland university hospital

    Bergen, 5021

  • Haugesund sanitetsforenings revmatismesykehus

    Haugesund, Haugesund, 5504

Other trials in Norway

About this study

Official title: Robotized Computer Navigation Versus Conventional Technique in Total Knee Replacement. A Randomized, Clinical and Radiostereometric Trial.

Navio is a new generation of computer navigation systems allowing intraoperative navigation of the bone cuts relative to both ligaments and skeletal axes, prior to bone removal. An improved accuracy is incorporated by the use of robotics in a burr for bone removal.

This study investigates whether this advanced technology leads to better clinical or radiostereometric results, by comparing one group operated with Navio to another group operated with conventional technique.

Read the detailed description

Background:

The scientific foundation of total knee replacement (TKR) surgery is incomplete. As a national governor of joint replacements, the Norwegian Arthroplasty Register is obligated to strict regulations, demanding high levels of evidence for implants and instruments utilized by Norwegian surgeons. It is well known that 15-20% of patients with a TKR, are dissatisfied. Nevertheless, only a small proportion of these patients have revision surgery.

In this randomized, clinical trial we will use the Journey II BCS total knee system, with a more native anatomical design, intended to improve the kinematics and functional outcomes by mimicking a native knee, with respect to geometry and its interplay with the ligaments and soft tissue envelope of the knee (i.e. the biomechanics; stability, joint line, off-set, sizing etc.). To achieve an optimal placement of the implant, the surgeon needs to assess a lot of information (experience) during the surgical procedure. To secure this process, and to make sure all aspects are taken into account, with respect to an optimal positioning and ligament balancing, the computer navigation technique may offer valuable input, with further enhancement of the accuracy and precision using precision tools like the Navio from Smith \& Nephew. The Navio system combines robotics and computer navigation, and represents the newest technology within surgical robotics and haptics. This trial is important in the mandatory evaluation process needed, before introducing new technology into orthopaedic surgery, on a larger scale.

Methods:

The surgeons involved have been trained at a wet lab, and on saw bones, before utilizing this tool in a live setting. After the introduction period, the training will continue in a clinical setting until the surgeons have operated at least 20 Navio assisted cases each, followed by a pilot study of 10 patients. All patients will be randomized to either Navio or Conventional technique.

Surgical method: A tourniquet is used. All implant components are cemented (Palacos R+G bone cement is utilized 10 minutes after retrieval from a 4 degrees Celsius refrigerator). Standard para-patellar approach. ACL and PCL are removed. Closing of the wound and capsule in mid-flexion position, Quill for the capsule, Vicryl for the subcutaneous tissue, continuous overlapping mattress with Ethilon suture for the skin. No drainage. Wrapping of the entire limb with elastic dressings for the first 48 hours. Prophylactic antibiotics and anticoagulants are given. Tranexamic acid to reduce bleeding. Postop pain medication: gabapentin, acetaminophen, naproxen, femoral triangle nerve block (repeated next day if needed).

For the conventional group: The rotational alignment is set according to Whiteside's line, and intramedullary rods with 5, 6 or 7 degrees valgus, are selected for the distal femoral cut (dependent on pre-operatively measured angles on long radiographs (hip-knee-ankle). The entry hole of the rod is plugged with bone from the femur to reduce bleeding from the intramedullary canal. The tibial component (metal) is positioned with a 3 degrees posterior slope.

For the Navio group: The cuts are navigated to optimize ligament balance in flexion and extension, and adjusted for mid-flexion instability when needed. A difference of less than 4 mm between lateral and medial gaps is accepted when the laxity is on the lateral side, preferably in flexion. However, if the gap balancing technique suggests a deviation from mechanical alignment of more than 2 degrees of valgus or 4 degrees of varus, the suggestion is overruled by the mechanical alignment (maximum 2 degrees valgus, less than 4 degrees varus).

Sample size calculations: To detect a clinically important difference of 0.17 in the rate of "high responders" and "non-responders" (OMERACT-OARSI criteria) to the Navio, with a standard deviation of 20, power 80% and a 0.05 significance level, a total of 194 patients must be included in the trial (97 patients in each group). The calculations are based on data from a previous study, by Petursson et al, JBJS Am 2018. When 10% eventual drop-outs are taken into account, the total number of patients to be included is 214 (107 patients in each group).

A large number of patients is important, as the expected difference between the groups is small. A small difference may be less clinically relevant, however, may contribute to an overall better outcome for the patients in total. A small improvement of the tools combined with other small improvements may add up to be clinically important in the end. Small trials with no significant differences may disqualify important small improvements, thus stopping any further development in the field. Consequently, large clinical trials will be valuable.

A radiostereometric analysis constitutes a separate study of the trial. A clinically relevant difference of 0.1 mm between the groups will be detected with a standard deviation of 0.1, power 80% and significance level 0.05, if 17 patients are included in each group. Including eventual drop-outs and an expectation of some failures due to the technically challenging investigation method (the RSA), a total of 30 patients will be included in each group. RSA radiographs will be collected within the first week after the operation, at 3 months, 1 year, 2 years and 5 years follow-ups.

The trial is approved by the regional ethics committee and the data inspectorate of Norway.

Being tested
Navio, Conventional
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NavioProcedure or surgery

    New generation computer navigation with haptics and robotics

  • ConventionalProcedure or surgery

    Total knee arthroplasty using conventional instruments

Study groups in NCT04525950
Study groupRoleWhat they receive
NavioExperimentalUsing the new technology during surgery
Receives: Procedure: Navio
ConventionalActive comparatorUsing the conventional surgical instruments
Receives: Procedure: Conventional

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) high responders

    Difference in rate (0.00-1.00) of high responders (calculated from KOOS)

    Measured: 3 months

  2. WOMAC high responders

    Difference in rate (0.00-1.00) of high responders (calculated from KOOS)

    Measured: 1 year

  3. WOMAC high responders

    Difference in rate (0.00-1.00) of high responders (calculated from KOOS)

    Measured: 2 years

  4. WOMAC high responders

    Difference in rate (0.00-1.00) of high responders (calculated from KOOS)

    Measured: 5 years

  5. Radiostereometric migration

    Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)

    Measured: 1 year

  6. Radiostereometric migration

    Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)

    Measured: 2 years

  7. Radiostereometric migration

    Maximum total point of motion MTPM (millimeters), (includes only first 60 patients)

    Measured: 5 years

Secondary outcomes (25)
  1. Knee injury and osteoarthritis outcome score (KOOS)

    Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0(worse)-100(better))

    Measured: 3 months

  2. Knee injury and osteoarthritis outcome score (KOOS)

    Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)

    Measured: 1 year

  3. Knee injury and osteoarthritis outcome score (KOOS)

    Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)

    Measured: 2 years

  4. Knee injury and osteoarthritis outcome score (KOOS)

    Symptoms, Stiffness, Pain, Activity of daily living, Sports, Quality of life subscores (0-100)

    Measured: 5 years

  5. Knee society score (KSS)

    Knee society score, knee score (0(worse)-100(better)) and function score (0(worse)-100(better))

    Measured: 3 months

  6. Knee society score (KSS)

    Knee society score, knee score (0-100) and function score (0-100)

    Measured: 1 year

  7. Knee society score (KSS)

    Knee society score, knee score (0-100) and function score (0-100)

    Measured: 2 years

  8. Knee society score (KSS)

    Knee society score, knee score (0-100) and function score (0-100)

    Measured: 5 years

  9. EQ-5D

    Euroqol, quality of life (0(worse)-100(better))

    Measured: 3 months

  10. EQ-5D

    Euroqol, quality of life (0-100)

    Measured: 1 year

  11. EQ-5D

    Euroqol, quality of life (0-100)

    Measured: 2 years

  12. EQ-5D

    Euroqol, quality of life (0-100)

    Measured: 5 years

  13. Visual analogue scale (VAS)

    Visual Analogue Scale pain (0(worse)-100(better))

    Measured: pre-op, 3 months, 1 year, 2 years, 5 years

  14. Forgotten Joint Score (FJS)

    Forgotten Joint Score (0(worse)-100(better))

    Measured: 3 months

  15. Forgotten Joint Score (FJS)

    Forgotten Joint Score (0-100)

    Measured: 1 year

  16. Forgotten Joint Score (FJS)

    Forgotten Joint Score (0-100)

    Measured: 2 years

  17. Forgotten Joint Score (FJS)

    Forgotten Joint Score (0-100)

    Measured: 5 years

  18. Maximum climb-up test

    Height (cm) of one stair climbed with affected/operated limb (no pulling by hands)

    Measured: 3 months

  19. Maximum climb-up test

    Height (cm) of one stair climbed with affected/operated limb (no pulling by hands)

    Measured: 1 year

  20. Anchor questions

    Are you satisfied with the outcome? Would you do it again?

    Measured: 2 years

  21. Anchor questions

    Are you satisfied with the outcome? Would you do it again?

    Measured: 5 years

  22. Timed 40 meters walking test

    Time spent walking 40 meters

    Measured: 3 months

  23. Timed 40 meters walking test

    Time spent (in seconds) walking 40 meters

    Measured: 1 year

  24. Chair test 30 seconds

    number of repetitions from sitting to standing position during 30 seconds

    Measured: 3 months

  25. Chair test 30 seconds

    number of repetitions from sitting to standing position during 30 seconds

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2020
  2. Study start7 Sep 2020
  3. Primary completion1 May 2023
  4. Study completion31 Dec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized, blinded (patient and outcomes assessor), clinical and radiostereometric trial
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
214 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04525950
Sponsor's protocol ID
2020/68448
Acronym
NavioRCT
Status last verified
Oct 2024
First submitted
17 Aug 2020
Last updated
14 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Batailler C, White N, Ranaldi FM, Neyret P, Servien E, Lustig S. Improved implant position and lower revision rate with robotic-assisted unicompartmental knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2019 Apr;27(4):1232-1240. doi: 10.1007/s00167-018-5081-5. Epub 2018 Jul 31.

    PubMed 30066017
  • Petursson G, Fenstad AM, Gothesen O, Dyrhovden GS, Hallan G, Rohrl SM, Aamodt A, Furnes O. Computer-Assisted Compared with Conventional Total Knee Replacement: A Multicenter Parallel-Group Randomized Controlled Trial. J Bone Joint Surg Am. 2018 Aug 1;100(15):1265-1274. doi: 10.2106/JBJS.17.01338.

    PubMed 30063588
  • Robinson PG, Clement ND, Hamilton D, Blyth MJG, Haddad FS, Patton JT. A systematic review of robotic-assisted unicompartmental knee arthroplasty: prosthesis design and type should be reported. Bone Joint J. 2019 Jul;101-B(7):838-847. doi: 10.1302/0301-620X.101B7.BJJ-2018-1317.R1.

    PubMed 31256672
  • Bollars P, Boeckxstaens A, Mievis J, Kalaai S, Schotanus MGM, Janssen D. Preliminary experience with an image-free handheld robot for total knee arthroplasty: 77 cases compared with a matched control group. Eur J Orthop Surg Traumatol. 2020 May;30(4):723-729. doi: 10.1007/s00590-020-02624-3. Epub 2020 Jan 16.

    PubMed 31950265
  • Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96. doi: 10.2519/jospt.1998.28.2.88.

    PubMed 9699158
  • Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and Osteoarthritis Outcome Score (KOOS)--validation of a Swedish version. Scand J Med Sci Sports. 1998 Dec;8(6):439-48. doi: 10.1111/j.1600-0838.1998.tb00465.x.

    PubMed 9863983
  • Heijbel S, Naili JE, Hedin A, W-Dahl A, Nilsson KG, Hedstrom M. The Forgotten Joint Score-12 in Swedish patients undergoing knee arthroplasty: a validation study with the Knee Injury and Osteoarthritis Outcome Score (KOOS) as comparator. Acta Orthop. 2020 Feb;91(1):88-93. doi: 10.1080/17453674.2019.1689327. Epub 2019 Nov 12.

    PubMed 31711349
  • Ko V, Naylor JM, Harris IA, Crosbie J, Yeo AE. The six-minute walk test is an excellent predictor of functional ambulation after total knee arthroplasty. BMC Musculoskelet Disord. 2013 Apr 24;14:145. doi: 10.1186/1471-2474-14-145.

    PubMed 23617377
  • Unver B, Kalkan S, Yuksel E, Kahraman T, Karatosun V. Reliability of the 50-foot walk test and 30-sec chair stand test in total knee arthroplasty. Acta Ortop Bras. 2015 Jul-Aug;23(4):184-7. doi: 10.1590/1413-78522015230401018.

    PubMed 26327798
  • Nyberg LA, Hellenius ML, Wandell P, Kowalski J, Sundberg CJ. Maximal step-up height as a simple and relevant health indicator: a study of leg muscle strength and the associations to age, anthropometric variables, aerobic fitness and physical function. Br J Sports Med. 2013 Oct;47(15):992-7. doi: 10.1136/bjsports-2013-092577. Epub 2013 Aug 21.

    PubMed 23966416
  • Gothesen O, Espehaug B, Havelin LI, Petursson G, Hallan G, Strom E, Dyrhovden G, Furnes O. Functional outcome and alignment in computer-assisted and conventionally operated total knee replacements: a multicentre parallel-group randomised controlled trial. Bone Joint J. 2014 May;96-B(5):609-18. doi: 10.1302/0301-620X.96B5.32516.

    PubMed 24788494
  • Inui H, Taketomi S, Yamagami R, Shirakawa N, Kawaguchi K, Tanaka S. The Relationship between Soft-Tissue Balance and Intraoperative Kinematics of Guided Motion Total Knee Arthroplasty. J Knee Surg. 2019 Jan;32(1):91-96. doi: 10.1055/s-0038-1636545. Epub 2018 Mar 7.

    PubMed 29514366
  • Iriuchishima T, Ryu K. Bicruciate Substituting Total Knee Arthroplasty Improves Stair Climbing Ability When Compared with Cruciate-Retain or Posterior Stabilizing Total Knee Arthroplasty. Indian J Orthop. 2019 Sep-Oct;53(5):641-645. doi: 10.4103/ortho.IJOrtho_392_18.

    PubMed 31488934
  • Harris AI, Christen B, Malcorps JJ, O'Grady CP, Kopjar B, Sensiba PR, Vandenneucker H, Huang BK, Cates HE, Hur J, Marra DA. Midterm Performance of a Guided-Motion Bicruciate-Stabilized Total Knee System: Results From the International Study of Over 2000 Consecutive Primary Total Knee Arthroplasties. J Arthroplasty. 2019 Jul;34(7S):S201-S208. doi: 10.1016/j.arth.2019.02.011. Epub 2019 Feb 14.

    PubMed 31031156
  • Kono K, Inui H, Tomita T, Yamazaki T, Taketomi S, Sugamoto K, Tanaka S. Bicruciate-stabilised total knee arthroplasty provides good functional stability during high-flexion weight-bearing activities. Knee Surg Sports Traumatol Arthrosc. 2019 Jul;27(7):2096-2103. doi: 10.1007/s00167-019-05375-9. Epub 2019 Apr 10.

    PubMed 30972466

Questions about this trial

What is this clinical trial studying?

A study testing Navio and Conventional in people with Arthritis, Degenerative and Osteo Arthritis Knee, run by Haukeland University Hospital at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) high responders (time frame: 3 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04525950, which also lists 18 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in